Mio Takahashi
Niijuku, 1258585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Caffeic acid phenethyl ester derivatives inhibit glyoxalase I activity and induce cell death in cultured cancer cell lines.
Journal: Bioorganic & medicinal chemistry letters
Published: June 22, 2026
Genomic, Trop-2, and Immune Profiles of Carcinomatous and Sarcomatous Components in Ovarian Carcinosarcoma.
Journal: Cancer reports (Hoboken, N.J.)
Published: August 05, 2025
A case of primary ovarian clear cell carcinoma with ETV6::NTRK3 fusion.
Journal: International cancer conference journal
Published: May 03, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.
Journal: Cancer research communications
Published: January 17, 2025
Case report of two long term ovarian cancer survivors with brain metastases following multimodal treatment including chemotherapy, radiotherapy and maintenance olaparib: An institutional case series and literature review.
Journal: Gynecologic oncology reports
Published: March 25, 2024
Albumin Hydrogel-Coated Mesoporous Silica Nanoparticle as a Carrier of Cationic Porphyrin and Ratiometric Fluorescence pH Sensor.
Journal: ACS applied bio materials
Published: January 11, 2024
A rare case of synchronous bilateral ovarian cancer with combined clear cell and mucinous carcinomas and brain metastases.
Journal: International cancer conference journal
Published: December 14, 2023
Optimal Administration of Glycyrrhizin Avoids Pharmacokinetic Interactions With High-dose Methotrexate and Exerts a Hepatoprotective Effect.
Journal: Anticancer research
Published: January 15, 2023
Massive Hemorrhage Due to Cervical Endometriotic Cyst Rupture: Two Case Reports and a Literature Review.
Journal: The American journal of case reports
Published: November 24, 2021
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer.
Journal: International journal of clinical oncology
Published: November 12, 2021
Last Updated: 09/26/2026